A discovery that could protect the eye and the brain

By Jan Jarvis

Eye Research with patient
UNT Health Science Center eye researchers have discovered a chemical that may help prevent irreversible vision loss caused by glaucoma and other retinal diseases.

Nerves in the inner retina carry signals through the optic nerve to the brain for vision recognition, said Abe Clark, PhD., Executive Director of UNTHSC’s North Texas Eye Research Institute.

Abe Clark, UNTHSC
Abe Clark, PhD.

“When the cells in the retina are damaged, then the cells that they connect to in the brain also become damaged,” Dr. Clark said. “When you lose certain nerves in the retina, you lose nerves in the center of the brain.”

But Dr. Clark and his team found that it may be possible to protect both the eye and brain using a chemical known as a JNK inhibitor. The research group exposed cultured retinal cells to several toxic insults while also using a mouse model of retinal ischemic stroke, resulting in nerve cell death in both the retina and brain.

By treating the retina cells with this chemical, the researchers were able to protect against ischemic nerve cell death. The discovery could lead to new therapies to prevent vision loss due to glaucoma and other retinal diseases. The work, which was supported by a grant from the Department of Defense, was published this month in Molecular Neurodegeneration.

“We suggest that the JNK signaling pathway is a prominent and critical path for neurodegeneration due to retinal stroke,” Dr. Clark said. “Treating the nerves with this inhibitor totally protected the retina and the nerves in the brain from functional damage.”

The discovery is believed to be applicable to a number of eye diseases, including glaucoma and diabetic retinopathy, he said. It could also have implications for brain diseases caused by blood flow blockage.

“The retina is part of the brain, and what we might have found is a way to protect the nerves in the brain from similar insults like a stroke,” Dr. Clark said. “We are excited about this as a potential new therapy for treating nerves in diseases with compromised blood flow.”

Recent News

4ce85696 80cc 4bc6 B20b 8e48bc261e0a
  • Our People
|Apr 26, 2024

College of Pharmacy students land dream fellowships

Rachel Clark, Sulin Kamt, Haley McKeefer and Elise Vo might be nearing the end of their time at The University of North Texas Health Science Center at Fort Worth’s UNT System College of Pharmacy, but their time learning what the pharmaceutical industry has to offer is far from over. After graduati...
Dharamsi Cropped
  • Our People
|Apr 26, 2024

School of Public Health Climbs in U.S. News & World Report Rankings

The University of North Texas Health Science Center at Fort Worth’s School of Public Health is climbing the ranks in the latest U.S. News & World Report rankings of public health schools. SPH jumped four spots in this year’s rankings to number 88. This rise in the rankings reflects SPH's co...
Mtawndy2mze
  • Community
|Apr 25, 2024

New TCOM-affiliated internal medicine residency at Paris Regional Health Gains ACGME approval

In a significant move to help address the growing primary care physician shortage in Texas, The University of North Texas Health Science Center at Fort Worth’s Texas College of Osteopathic Medicine and Paris Regional Health are now approved for a new Internal Medicine Residency Program. The Accre...
Amanda
  • On Campus
|Apr 24, 2024

HSC to host HIV Symposium

HIV remains a major global health issue, with an estimated 40 million people living with HIV worldwide. About 10 million of them, including about half of infected children, do not have access to treatment. From 9:30 a.m. to noon on Monday, health care providers working on the frontlines of the HIV ...